SCHEMBL6038174

SCHEMBL6038174

Nc1ccc(SCC(=O)NCCCCCC(=O)Nc2ccc(Oc3ccccc3)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 11/20 0.56
HDAC4 P56524 11/20 0.56
HDAC1 Q13547 11/20 0.56
HDAC7 Q8WUI4 11/20 0.56
HDAC2 Q92769 11/20 0.56
HDAC10 Q969S8 11/20 0.56
HDAC11 Q96DB2 11/20 0.56
HDAC8 Q9BY41 11/20 0.56
HDAC6 Q9UBN7 11/20 0.56
HDAC9 Q9UKV0 11/20 0.56
HDAC5 Q9UQL6 11/20 0.56
LTA4H P09960 3/20 0.49
LMNA P02545 2/20 0.48
ALDH1A1 P00352 1/20 0.48
MEN1 O00255 1/20 0.48
HPGD P15428 1/20 0.48
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
RNF4 P78317 1/20 0.47
TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6038042 0.90 HDAC6 (0.67) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6037971 0.84 KDM4E (0.55) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL5998948 0.83 HDAC3 (0.80) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL5241147 0.82 HDAC4 (0.70) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL5278693 0.82 HDAC6 (0.58) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL8272105 0.81 HDAC3 (0.67) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6037913 0.78 ALDH1A1 (0.58) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL9240178 0.77 HDAC1 (0.83) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL5278452 0.77 HDAC1 (0.67) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL6038318 0.76 HDAC3 (0.58) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US claimed
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264415-A1 Inhibitors of histone deacetylase HDAC1, HDAC3, HDAC11 HDAC3 2/4885HDAC4 7/4885HDAC1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.